Scholarlink

Background <p>Chinese individuals may seek chin enhancement to address esthetic perceptions regarding chin retrusion. Because studies of the injectable hyaluronic acid gel VYC-25L (Allergan Aesthetics, an AbbVie Company, Irvine, CA) contained few Asian subjects and none from China, its effects on chin retrusion in Chinese individuals are unclear. This 12-month, real-world evidence study evaluated the safety and effectiveness of VYC-25L for chin enhancement in Chinese adults.</p> Methods <p>At Hainan Bo’ao Super Hospital, 2 cohorts of prospectively and retrospectively enrolled adults received VYC-25L treatment (maximum 4 mL). Cohort 1 only underwent 3D imaging before and after treatment for digital analysis. The primary effectiveness measure was mean change from baseline in glabella–subnasale–pogonion (G–Sn–Pog) angle at month 3 based on 3D facial images. Both cohorts completed the Global Aesthetic Improvement Scale (GAIS; subjects and investigators) and a satisfaction questionnaire (subjects). Injection site response (ISR) and adverse events were recorded.</p> Results <p>Of 90 subjects enrolled (cohort 1, n=36; cohort 2, n=54), 89 completed the study. Mean change from baseline in G–Sn–Pog angle at month 3 was 3.19 degrees (95% CI, 2.55–3.83; <i>P</i> &lt; 0.001 vs 0), with improvement maintained through 12 months. Month 3 “improved”/“much improved” GAIS responder frequencies were 94.3% (investigators) and 97.1% (subjects); 91.5% of subjects were “satisfied”/“very satisfied” with treatment at month 3. Most (&gt;70%) ISRs were mild or moderate in severity. Four treatment-related adverse events occurred (all mild).</p> Conclusion <p>VYC-25L was safe and effective for enhancement of the chin and jaw in Chinese adults.</p> Level of Evidence III <p>This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors <a href="http://www.springer.com/00266">www.springer.com/00266</a>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hyaluronic Acid Injectable Gel VYC-25L Is Safe and Effective for Adults Seeking Chin Enhancement to Correct Chin Retrusion: Results From a Real-world Evidence Study in China

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月26日

查看全文
  • Yimin Liang,
  • Wang Zhan,
  • Yun Xie,
  • Danru Wang,
  • Qingfeng Li,
  • Grace Zhao,
  • Smita Chawla

摘要

Background

Chinese individuals may seek chin enhancement to address esthetic perceptions regarding chin retrusion. Because studies of the injectable hyaluronic acid gel VYC-25L (Allergan Aesthetics, an AbbVie Company, Irvine, CA) contained few Asian subjects and none from China, its effects on chin retrusion in Chinese individuals are unclear. This 12-month, real-world evidence study evaluated the safety and effectiveness of VYC-25L for chin enhancement in Chinese adults.

Methods

At Hainan Bo’ao Super Hospital, 2 cohorts of prospectively and retrospectively enrolled adults received VYC-25L treatment (maximum 4 mL). Cohort 1 only underwent 3D imaging before and after treatment for digital analysis. The primary effectiveness measure was mean change from baseline in glabella–subnasale–pogonion (G–Sn–Pog) angle at month 3 based on 3D facial images. Both cohorts completed the Global Aesthetic Improvement Scale (GAIS; subjects and investigators) and a satisfaction questionnaire (subjects). Injection site response (ISR) and adverse events were recorded.

Results

Of 90 subjects enrolled (cohort 1, n=36; cohort 2, n=54), 89 completed the study. Mean change from baseline in G–Sn–Pog angle at month 3 was 3.19 degrees (95% CI, 2.55–3.83; P < 0.001 vs 0), with improvement maintained through 12 months. Month 3 “improved”/“much improved” GAIS responder frequencies were 94.3% (investigators) and 97.1% (subjects); 91.5% of subjects were “satisfied”/“very satisfied” with treatment at month 3. Most (>70%) ISRs were mild or moderate in severity. Four treatment-related adverse events occurred (all mild).

Conclusion

VYC-25L was safe and effective for enhancement of the chin and jaw in Chinese adults.

Level of Evidence III

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.